Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Shuangyan Health Industry Group is a comprehensive healthcare conglomerate based in Datong, Shanxi Province, China. The group operates across the entire pharmaceutical value chain, including research and development, manufacturing, and distribution of both chemical drugs and Traditional Chinese Medicine (TCM). Its core subsidiary, Shanxi Shuangyan Pharmaceutical, produces a wide range of formulations such as tablets, capsules, and injections targeting cardiovascular, digestive, and respiratory conditions. The company is recognized for its "Shuangyan" brand and maintains large-scale GMP-certified manufacturing facilities. It plays a significant role in the regional economy and the supply of essential medicines in Northern China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Shuangyan Health Industry Group.